Grace Therapeutics Statistics
NASDAQ: GRCEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.71-0.01 (-0.58%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Grace Therapeutics by the numbers
Grace Therapeutics has a market capitalization of $36.0 million based on 21.04M shares outstanding. With trailing EPS of $-1.16, Grace Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.0% below its 50-day average and 36.1% below its 200-day average.
Average daily trading volume is 119.27K shares, or about $203,953 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GRCE valuation vs. peer median
| Metric | GRCE | Peer median | Difference |
|---|---|---|---|
| Market cap | $35.97M | $35.79M | +1% |
| Avg. volume | 119.27K | 333.40K | -64% |
Peer median across 8 companies: PLRX, SDEV, CNTB, CUE, DWTX, VERU, ATNM, HYFT.
Valuation
- Market cap
- $35.97M
- EPS (TTM)
- $-1.16
- Shares outstanding
- 21.04M
Price and trading
- Previous close
- 1.72
- Open
- 1.71
- Day range
- 1.68 – 1.82
- 52-week range
- 1.64 – 5.18
- 52-week change
- -46.39%
- Beta
- —
- Volume
- 153.91K
- Average volume
- 119.27K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jun 20, 2025
Additional statistics
- Market Cap
- 35.97M
- Forward Pe
- -4.03
- Eps
- -1.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.18
- Week52 Low
- 1.64
- Avg Volume
- 119.27K
- Shares Outstanding
- 21.04M
- Ma50
- 1.97
- Ma200
- 2.68
- Earnings Date
- Jun 20, 2025
- Pct From52w High
- -66.99%
- Pct From52w Low
- 4.27%